Mukesh Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.02 Cr
- Revenue Growth 22.78%
- Profit Growth 113.52%
- Ebitda 58.74%
- Net Worth 41.82%
- Total Assets 78.88%
About Mukesh Pharma
Mukesh Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2019 (Five years and four months 16 days old ). Its registered office is in Noida, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.02 Cr.
Manju Mahto, Lalan Mahto, Menka Mahto, and One other member serve as directors at the Company.
Company Details
-
Location
Noida, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909UP2019PTC121433
-
Company No.
121433
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Mukesh Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manju Mahto
|
Director | 16-Dec-2019 | Current |
|
Lalan Mahto
|
Director | 16-Dec-2019 | Current |
|
Menka Mahto
|
Director | 19-Sep-2019 | Current |
|
Mukesh Mahto
|
Director | 19-Sep-2019 | Current |
Financial Performance of Mukesh Pharma.
Mukesh Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.78% increase. The company also saw a substantial improvement in profitability, with a 113.52% increase in profit. The company's net worth Soared by an impressive increase of 41.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mukesh Pharma?
In 2023, Mukesh Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hygieneherbs Agro Fresh Private LimitedManju Mahto is a mutual person
Charges (Loans)
₹10.16 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.88 Cr
- Hdfc Bank Limited : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Oct 2023 | Others | ₹8.75 M | Open |
| 05 Jan 2021 | Hdfc Bank Limited | ₹1.41 M | Open |
How Many Employees Work at Mukesh Pharma?
Unlock and access historical data on people associated with Mukesh Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mukesh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mukesh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.